ArticlePloS one2026
Large-scale cryptic proteome mining revealed potential phage-mediated host-pathogen genetic exchange in Mycobacterium tuberculosis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDue to inevitable evolution, clinical strains of Mycobacterium tuberculosis (Mtb) exhibit distinct phenotypes and differ significantly from laboratory strains. This divergence is driven by the acquisition of diverse mutations, intragenomic recombination, and potentially phage-mediated genetic exchange. Further investigation is therefore required to better understand these differences, especially regarding the emergence of novel open reading frames (ORFs). METHODOLOGY: A large-scale whole-genome sequencing (WGS) dataset from tuberculosis (TB)-endemic countries was assembled into contigs. These contigs were then used to mine the cryptic proteome through in silico predictions, using an emerging state-of-the-art deep learning protein language model, ProtBERT. Structures of emerging ORF proteins were predicted using colabfold2. In addition, Ramachandran plot analysis and molecular dynamics simulation (MDS) were performed to assess structural validity and stability.
resultsMost small cryptic proteins were derived from PE, PPE, and PE-PGRS family genes. Notably, a protein cluster consisting sequences of 101-300 amino acids showed no similarity with the proteins from the reference Mtb H37Rv strain but contained phage-derived domains and sequences homologous to host (primates) DNA. Sub-stratification of this cluster revealed the presence of domains like reverse transcriptases and other phage-associated proteins. BLASTp hits of these proteins showed similarity between these proteins and the host proteome. Structural validation showed that the Phi/Psi angles of modelled proteins were within the accepted ranges. Moreover, MDS of medoids of subclusters displayed stable root mean square deviation (RMSD) and radius of gyration (RGYR) profiles, supporting the structural plausibility of these proteins. Importantly, one sub-cluster showed a higher presence in drug-resistant Mtb strains. The co-occurrence of phage-related domains and host DNA strongly suggests illegitimate phage-mediated lateral transfer of host nucleic acids into the genome of Mtb.
conclusionThe majority of the small ORFs are found to be nested within annotated genes. Particular emphasis has been given to the incidental finding of phage-host chimeric ORF signatures within the Mtb genome. This study provides computational evidence supporting the structural stability of these proteins. Thus, it can be speculated that such proteins may contribute to pathogenicity, survival within the host, or molecular mimicry mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.